First Affiliated Hospital, Sun Yat-sen University

This study tested a three-part treatment for people with colorectal cancer that spread to the liver and stopped responding to standard therapies. The treatment combined targeted chemotherapy beads injected into the liver, chemotherapy infusion into the liver artery, and a targete…

This study looked at whether a combination of two pain medicines (hydromorphone and flurbiprofen) could help control pain during and after a liver cancer treatment called TACE. 129 adults with intermediate-to-advanced liver cancer took part. The goal was to see if this approach c…

This study looked at 324 adults with intermediate-stage liver cancer to see if CT scan features could predict how well they would respond to a combination treatment of targeted therapy and a procedure that blocks the tumor's blood supply. The goal was to find out if certain scan …

This study looked at 169 people with a type of liver cancer called intrahepatic cholangiocarcinoma. Researchers used MRI scans and machine learning to measure scar tissue and a specific protein in the tumors. The goal was to see if these features could help predict how long patie…

This study tested a computer model that helps doctors decide which liver cancer patients with bile duct tumor clots will benefit most from surgery. Researchers analyzed data from 151 patients to see if following the model's advice improved survival. The goal was to make surgical …

This completed study looked at 328 patients with intermediate or high-risk gastrointestinal stromal tumors (GIST) who took imatinib after surgery. The goal was to find the best dose that balances effectiveness and side effects. Researchers measured drug levels in the blood and tr…

This study looked at medical scans from 3,000 liver cancer patients to see if artificial intelligence could predict who would benefit more from one of two standard treatments: TACE or HAIC. Researchers used a computer model to group patients by tumor features seen on scans. The g…